scholarly journals Correlation of transient elastography with hepatic venous pressure gradient in patients with cirrhotic portal hypertension: A study of 326 patients from India

2017 ◽  
Vol 23 (4) ◽  
pp. 687 ◽  
Author(s):  
Ashish Kumar ◽  
Noor Muhammad Khan ◽  
Shrihari Anil Anikhindi ◽  
Praveen Sharma ◽  
Naresh Bansal ◽  
...  
2021 ◽  
Vol 27 (1) ◽  
pp. 197-206
Author(s):  
Se Ri Ryu ◽  
Jeong-Ju Yoo ◽  
Seong Hee Kang ◽  
Soung Won Jeong ◽  
Moon Young Kim ◽  
...  

Background/Aims: The hepatic venous pressure gradient (HVPG) reflects portal hypertension, but its measurement is invasive. Transient elastography (TE) is a noninvasive method for evaluating liver stiffness (LS). We investigated the correlation between the value of LS, LS to platelet ratio (LPR), LS-spleen diameter-to-platelet ratio score (LSPS) and HVPG according to the etiology of cirrhosis, especially focused on alcoholic cirrhosis.Methods: Between January 2008 and March 2017, 556 patients who underwent HVPG and TE were consecutively enrolled. We evaluated LS, LPR, and LSPS according to the etiology of cirrhosis and analyzed their correlations with HVPG.Results: The LS value was higher in patients with alcoholic cirrhosis than viral cirrhosis based on the HVPG (43.5 vs. 32.0 kPa, P<0.001). There were no significant differences in the LPR or LSPS between alcoholic and viral cirrhosis groups, and the areas under the curves for the LPR and LSPS in subgroups according to HVPG levels were not superior to that for LS. In alcoholic cirrhosis, the LS cutoff value for predicting an HVPG ≥10 mmHg was 32.2 kPa with positive predictive value (PPV) of 94.5% and 36.6 kPa for HVPG ≥12 mmHg with PPV of 91.0%.Conclusions: The LS cutoff value should be determined separately for patients with alcoholic and viral cirrhosis. In alcoholic cirrhosis, the LS cutoff values were 32.2 and 36.6 kPa for predicting an HVPG ≥10 and ≥12 mmHg, respectively. However, there were no significant differences in the LPR or LSPS between alcoholic and viral cirrhosis groups.


2015 ◽  
Vol 148 (4) ◽  
pp. S-646-S-647
Author(s):  
Ohad Etzion ◽  
Akeem Adebogun ◽  
Jason Eccleston ◽  
Ahmed M. Gharib ◽  
David E. Kleiner ◽  
...  

Author(s):  
Fahim Ebrahimi ◽  
David Semela ◽  
Markus Heim

Abstract Background Measurement of the hepatic venous pressure gradient (HVPG) is the gold standard to evaluate the presence and severity of portal hypertension. The procedure is generally safe and well tolerated, but nevertheless, some patients demand for sedation. However, it is unknown whether propofol sedation would impair the accuracy of portal pressure measurements. Methods This is a prospective observational cohort study including cirrhotic patients with suspected portal hypertension undergoing invasive measurement of HVPG. Measurements of HVPG were performed in awake condition as well as under sedation with propofol infusion. Results In total, 37 patients were included. Mean HVPG in awake condition was 15.9 mmHg (IQR 13–19) and during sedation 14.1 mmHg (IQR 12–17). While measures of free hepatic vein pressure (FHVP) were not altered after propofol sedation (p = 0.34), wedged hepatic vein pressure values (WHVP) decreased in an average by  2.05 mmHg (95% CI − 2.46 to − 1.16; p < 0.001) which was proportional to the magnitude of HVPG. In 31 out of 37 patients (83.8%), portal hypertension with HVPG ≥ 12 mmHg was found. Under sedation with propofol, two patients (5.4%) with borderline values would have been incorrectly classified as < 12 mmHg. After adjustment for the average difference of − 10%, all patients were correctly classified. Intraclass correlation coefficient between HVPG measurement in awake condition and under propofol sedation was 0.927 (95% CI 0.594–0.975). Conclusions Propofol sedation during HVPG measurements is generally safe, however it may lead to relevant alterations of HVPG readings.


Medicina ◽  
2013 ◽  
Vol 49 (11) ◽  
pp. 73 ◽  
Author(s):  
Vilma Silkauskaite ◽  
Jouzas Kupčinskas ◽  
Andrius Pranculis ◽  
Laimas Jonaitis ◽  
Vitalija Petrenkiene ◽  
...  

Background and Objective: Alternative drug therapies are needed for the treatment of portal hypertension.[...]


Sign in / Sign up

Export Citation Format

Share Document